Skip to main content
Journal cover image

Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population.

Publication ,  Journal Article
Gurumoorthi, M; Dabbagh, GS; Wolfe, R; Hesse, K; Shah, R; Kurzlechner, L; Yadav, K; Balint, B; Asatryan, B; Sheikh, F; Chahal, CAA; Landstrom, AP
Published in: Heart Rhythm
October 21, 2025

BACKGROUND: Desmoplakin (DSP) variants cause arrhythmogenic cardiomyopathy, a disorder characterized by myocardial fibrosis, arrhythmias, and sudden cardiac death. DSP-mediated arrhythmogenic cardiomyopathy often involves left ventricular dysfunction and myocardial inflammation, yet existing diagnostic criteria may underdetect disease, underscoring the need for population-based penetrance estimates. OBJECTIVE: This study aimed to assess the prevalence and phenotypic penetrance of DSP variants in a genotyped population. METHODS: Among 200,580 UK Biobank participants with exome sequencing, DSP variants were classified as predicted deleterious (pDel), predicted loss of function (pLOF), or ClinVar 2∗ pathogenic/likely pathogenic (P/LP). A subset of pDel carriers underwent electrocardiographic (ECG) and cardiac magnetic resonance testing, matched to genotype-negative controls. Phenotypic penetrance was assessed using the International Classification of Diseases, Tenth Revision, diagnoses, ECG, and cardiac magnetic resonance imaging. Variant clustering within functional DSP domains was also evaluated. RESULTS: Of 200,580 participants, 1407 (0.7%) carried a pDel, 168 (0.08%) a pLOF, and 44 (0.02%) a ClinVar 2∗ P/LP DSP variant. Myocarditis occurred in 0.28% of pDel, 1.8% of pLOF, and 4.5% of ClinVar P/LP carriers vs 0.07% of controls (P < .05). Cardiomyopathy prevalence increased from 1.4% (pDel) to 5.4% (pLOF) and 6.8% (P/LP) vs 0.6% in controls (P < .01). DSP carriers had more frequent lateral T-wave inversions and abnormal left ventricular strain. Missense variants clustered within 2 functional DSP domains. CONCLUSION: DSP pDel variants are common but show low penetrance for myocarditis and cardiomyopathy, with risk increasing with more stringent classification. ECG and strain abnormalities may aid early detection, supporting genotype-first approaches for DSP interpretation.

Duke Scholars

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

October 21, 2025

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
  • 0903 Biomedical Engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurumoorthi, M., Dabbagh, G. S., Wolfe, R., Hesse, K., Shah, R., Kurzlechner, L., … Landstrom, A. P. (2025). Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.10.043
Gurumoorthi, Manasa, Ghaith Sharaf Dabbagh, Rachel Wolfe, Kerrick Hesse, Ravi Shah, Leonie Kurzlechner, Kanishk Yadav, et al. “Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population.Heart Rhythm, October 21, 2025. https://doi.org/10.1016/j.hrthm.2025.10.043.
Gurumoorthi M, Dabbagh GS, Wolfe R, Hesse K, Shah R, Kurzlechner L, et al. Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population. Heart Rhythm. 2025 Oct 21;
Gurumoorthi, Manasa, et al. “Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population.Heart Rhythm, Oct. 2025. Pubmed, doi:10.1016/j.hrthm.2025.10.043.
Gurumoorthi M, Dabbagh GS, Wolfe R, Hesse K, Shah R, Kurzlechner L, Yadav K, Balint B, Asatryan B, Sheikh F, Chahal CAA, Landstrom AP. Disease penetrance and phenotypic spectrum of desmoplakin variant carriers in the population. Heart Rhythm. 2025 Oct 21;
Journal cover image

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

October 21, 2025

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
  • 0903 Biomedical Engineering